| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507649 | Acta Pharmaceutica Sinica B | 2018 | 24 Pages |
Abstract
This review discusses the current state and advances in the field of personalized medicine for lung cancer, reviewing several of the mutation-targeting strategies that are approved for clinical use and how they are guided by patient genetic information, and finally provide the viewpoints on the future of personalized medicine in lung cancer.211
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Wenxiao Jiang, Guiqing Cai, Peter C. Hu, Yue Wang,